Direct comparison
BPC-157 vs TB-500
How BPC-157 and TB-500 compare on mechanism, evidence and legal status — factual, no recommendations.
| BPC-157 | TB-500 | |
|---|---|---|
| Class | BPC | Thymosin |
| Evidence level | preclinical | preclinical |
| Legal status (DE) | not approved | not approved |
| WADA-listed | Yes | Yes |
| Molar mass | 1419.5 Da | 4963 Da |
| Studies cited | 3 | 3 |
| Research areas | Recovery, Immunomodulation | Recovery, Muscle growth, Immunomodulation |
BPC-157
BPC-157 is a synthetic pentadecapeptide derived from a partial sequence of a human gastric juice protein.
Full BPC-157 profileTB-500
TB-500 (as a synthetic analog of thymosin beta-4, a naturally occurring peptide) interacts with G-actin and regulates actin polymerisation in cells.
Full TB-500 profileImportant notice
This site is intended solely for factual, scientifically oriented information about peptides. It does not constitute medical advice, does not replace a consultation with a doctor and contains no recommendations for use in humans.
This site does not sell any substances and names no sources for unapproved substances. For medical questions, please consult qualified medical professionals.